Recent innovations in the development of magnetic resonance imaging conditional pacemakers and implantable cardioverter-defibrillators.

The first generation of magnetic resonance conditional pacemakers and implantable cardioverter-defibrillators has finally arrived in clinical practice after many years of development. These devices have been optimized to properly function within magnetic fields of 1.5 T and ensure safe operation in controlled environments. Further progress is needed to develop a new generation of magnetic resonance imaging (MRI) conditional devices that can operate in higher powered MRI machines (3 T) which produce clearer images. (Cardiol J 2012; 19, 1: 98–104)

[1]  John Gosbee,et al.  ACR guidance document for safe MR practices: 2007. , 2007, AJR. American journal of roentgenology.

[2]  B. Stevenson,et al.  Issues and Design Solutions Associated with Performing MRI Scans on Patients with Active Implantable Medical Devices , 2007, 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[3]  Ron Kalin,et al.  Current Clinical Issues for MRI Scanning of Pacemaker and Defibrillator Patients , 2005, Pacing and clinical electrophysiology : PACE.

[4]  Henry Krum,et al.  Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept. , 2009, Hypertension.

[5]  K Bachmann,et al.  Effects of magnetic resonance imaging on cardiac pacemakers and electrodes. , 1997, American heart journal.

[6]  F G Shellock,et al.  Cardiac pacemakers and implantable cardioverter defibrillators are unaffected by operation of an extremity MR imaging system. , 1999, AJR. American journal of roentgenology.

[7]  P Boesiger,et al.  Force and Torque Effects of a 1.5‐Tesla MRI Scanner on Cardiac Pacemakers and ICDs , 2001, Pacing and clinical electrophysiology : PACE.

[8]  F. Shellock,et al.  Assessment of MRI issues for a 3-T "immune" programmable CSF shunt valve. , 2011, AJR. American journal of roentgenology.

[9]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[10]  M. Das,et al.  Modern Pacemakers - Present and Future , 2011 .

[11]  T. Ogihara,et al.  The role of sympathetic nervous activity in renal injury and end-stage renal disease , 2010, Hypertension Research.

[12]  Frank G. Shellock,et al.  Reference Manual for Magnetic Resonance Safety, Implants, and Devices , 2009 .

[13]  R. Fimmers,et al.  Safety, feasibility, and diagnostic value of cardiac magnetic resonance imaging in patients with cardiac pacemakers and implantable cardioverters/defibrillators at 1.5 T. , 2011, American heart journal.

[14]  H. Schild,et al.  Magnetic resonance imaging in patients with cardiac pacemakers. , 2005, Journal of the American College of Cardiology.

[15]  Ó. Cano,et al.  Cardiac magnetic resonance imaging at 1.5 T in patients with cardiac rhythm devices. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[16]  Krzysztof Bartus,et al.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study , 2009, The Lancet.

[17]  J Leal Del Ojo,et al.  Is Magnetic Resonance Imaging Safe in Cardiac Pacemaker Recipients? , 2005, Pacing and clinical electrophysiology : PACE.

[18]  Patrick M Colletti,et al.  Magnetic resonance imaging in patients with cardiac pacemakers: era of "MR Conditional" designs , 2011, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[19]  Giovanni Calcagnini,et al.  In vitro investigation of pacemaker lead heating induced by magnetic resonance imaging: Role of implant geometry , 2008, Journal of magnetic resonance imaging : JMRI.

[20]  F. Shellock,et al.  "MR-conditional" pacemakers: the radiologist's role in multidisciplinary management. , 2011, AJR. American journal of roentgenology.

[21]  M. Böhm,et al.  Is there a role for renal sympathetic denervation in the future treatment of resistant hypertension? , 2011, Future cardiology.

[22]  Henry R. Halperin,et al.  Modern Pacemaker and Implantable Cardioverter/Defibrillator Systems Can Be Magnetic Resonance Imaging Safe: In Vitro and In Vivo Assessment of Safety and Function at 1.5 T , 2004, Circulation.

[23]  D. Bluemke,et al.  Safety of Magnetic Resonance Imaging in Patients With Cardiovascular Devices: An American Heart Association Scientific Statement From the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention , 2007, Circulation.

[24]  V. Papademetriou,et al.  Renal sympathetic denervation and systemic hypertension. , 2010, The American journal of cardiology.